DJIA 17,848.97 129.05 0.73%
NASDAQ 5,138.07 29.41 0.58%
S&P 500 2,087.86 7.45 0.36%
market minute promo

Pfizer (NYSE: PFE)

33.14 0.37 (1.13%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

PFE $33.16 1.19%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $33.00
Previous Close $32.77
Daily Range $32.80 - $33.14
52-Week Range $28.47 - $36.46
Market Cap $204.6B
P/E Ratio 24.64
Dividend (Yield) $1.12 (3.4%)
Ex-Dividend Date
Dividend Pay Date
Volume 8,099,594
Average Daily Volume 40,422,057
Current FY EPS $2.18




Drug Makers

Pfizer (PFE) Description

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra. Website:

News & Commentary

The Path Is Clear for a New Immunotherapy Entrant

The good news keeps piling up for avelumab and its developing duo.

Pfizer Is At A 'Strategic Crossroads'

Barclays On Merck: Too Much Underlying Value To Ignore

Jim Cramer's Top Takeaways: Allergan, Signet Jewelers, Tiffany

5 Top Income Stocks Boosting Their Already Big Payout

Dow Jones Industrial Average Falls 78 Points on Cyber Monday

3 Companies That Could Become Tax Inversion Targets

The Pfizer-Allergan deal may not be the last tax inversion deal we witness. These three companies could also become the target of a U.S.-based buyer.

Sosei Subsidiary Heptares Announces Strategic Drug Discovery Collaboration with Pfizer

Insurers Don't Want to Pay for Pricey Cancer Meds

High-priced cancer drugs are increasingly being placed in the highest tiers of insurers' drug formularies.

Pfizer-Allergan Merger: More Than A U.S. Tax Dodge? (Video)

See More PFE News...

PFE's Top Competitors

PFE $33.14 (1.13%)
Current stock: PFE
JNJ $101.47 (0.23%)
Current stock: JNJ
ROG $55.76 (0.60%)
Current stock: ROG
GSK $40.59 (0.20%)
Current stock: GSK